A shadow market for unapproved weight-loss drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, based on recent findings.
Experimental Drug Gaining Popularity Via Social Media
The experimental drug, which is still in clinical trials, is being advertised by online personalities for its alleged weight-reducing effects. Followers are encouraged to contact these accounts privately for supplier links, while also receiving discount codes.
Thriving Trade on Messaging Platforms
Additionally, a flourishing market exists on messaging services, where groups with thousands of members share “before and after” photos, injection guides and claims of rapid British shipping. Sellers market the drug there before redirecting buyers to WhatsApp for purchases.
Learning About Retatrutide
This medication is an investigational injection created by US drugmaker Eli Lilly. The treatment affects three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could help individuals lose up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being promoted digitally as the successor to Ozempic.
Healthcare Professionals Express Worries
Nevertheless, physicians and pharmacists have warned that the distribution of what remains an unapproved drug in the United Kingdom is worrisome and could lead to individuals administering substances of unknown origin.
Several professionals stated the popularity for retatrutide could be connected to the rising price of licensed slimming treatments such as Mounjaro.
Legal Status and Implementation
Selling the unapproved drug on social media or Telegram is illegal in the UK, as it is an unlicensed drug that must not be promoted or distributed for human use under the British medical regulations.
Several content creators try to sidestep the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted substance, but advertising and supply can still violate pharmaceutical, advertising, and customer regulations, risking penalties, legal action or imprisonment.
Service Response and Material Removal
Based on the social media company, the service has removed problematic material and prohibited related keywords and query recommendations. The organization said it was dedicated to keeping the service safe and investing in strengthening enforcement strategies.
Digital Marketplace Operations
Research also discovered communities with up to 9,000 members marketing the experimental drug using Telegram's built-in discovery tool, which functions like a public directory. Entering “retatrutide” instantly brings up channels with thousands of users, populated with photos of weight loss, positive testimonials and detailed instructions for mixing or administering at home.
After minutes of joining one community, a seller shared contact information, where the majority of transactions occur. The seller sent an instruction manual and guaranteed delivery within two days. When asked whether the product was genuine, one seller said: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. None inquired about weight, medical conditions or past usage.
Product Information and Costs
Within these groups, posts show black plastic parcels with postal service labels, stating to include fresh supplies. One message stated: “It took eight of us to load them this morning.”
Customers can select between dry substance containers, mixed at residence with sterile water, or pre-filled pens usually sold at 160 pounds for 20 milligrams. When questioned how much time a pen should be used, vendors give contradictory responses ranging from a several days to “depends on your body”.
Service Moderation and Security Measures
A spokesperson for the messaging service said it actively monitored harmful material on its platform including material that encouraged the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.
Healthcare Professional Cautions
“Individuals are administering substances they can’t verify. Even if the research behind this drug is valid, these digital versions may not contain what they advertise,” stated a pharmacy expert, the director of pharmacy at Chemist4U.
Dr Crystal Wyllie of Asda Online Doctor linked the increase in demand to recent cost increases for authorized slimming medications such as Mounjaro. “With prices rising, individuals are using online platforms. But fake injections are extremely risky. You cannot know what’s contained or whether the conditions they were made in was clean,” she said.
Her team has previously seen individuals harmed by self-injection from unconfirmed suppliers. “We understand the disappointment, but buying from messaging apps or communication platforms is gambling with your well-being,” stated the doctor. “These materials could be impure or incorrectly dosed.”
Manufacturer Position
A representative from the pharmaceutical company said retatrutide was in third stage clinical trials and had not been reviewed or approved by any regulatory agency globally. “Consequently at this point no one can market [it] for personal consumption,” they explained, adding that any item “misleadingly claiming itself as a company experimental substance not yet authorized … may subject users to possibly serious health risks”.
